CareDx (NASDAQ:CDNA – Get Free Report) and BioNexus Gene Lab (NASDAQ:BGLC – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, valuation, profitability and analyst recommendations. Valuation and Earnings This table compares CareDx […]
Stephens reaffirmed their overweight rating on shares of CareDx (NASDAQ:CDNA – Free Report) in a report issued on Wednesday morning, Benzinga reports. The brokerage currently has a $15.00 target price on the stock. CareDx Stock Up 3.0 % Shares of CDNA stock opened at $8.31 on Wednesday. The firm has a market cap of $430.29 […]
Redx Pharma Plc (LON:REDX – Get Free Report) insider Lisa Anson purchased 115,000 shares of the firm’s stock in a transaction on Tuesday, April 16th. The shares were acquired at an average cost of GBX 9 ($0.11) per share, with a total value of £10,350 ($12,884.35). Lisa Anson also recently made the following trade(s): On […]
Redx Pharma Plc (LON:REDX – Get Free Report)’s share price hit a new 52-week low during mid-day trading on Friday . The company traded as low as GBX 4 ($0.05) and last traded at GBX 4.30 ($0.05), with a volume of 8616193 shares. The stock had previously closed at GBX 7.50 ($0.09). Redx Pharma Price […]
AUSTIN, Texas, February 27, 2024 Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced the next phase of proceedings in its patent infringement litigation against CareDx. The U.S. District Court for the District of Delaware will now determine if CareDx owes a royalty for future infringement related to ongoing and future AlloSure testing occurring after August 2023.